Persistence of an Intact Endometrial Matrix and Vessels Structure in Women Exposed to VA-2914, a Selective Progesterone Receptor Modulator
Author(s) -
Stéphanie Ravet,
Carine Munaut,
Silvia Blacher,
Géraldine Brichant,
Soraya Labied,
Aude Béliard,
Nathalie ChabbertBuffet,
Philippe Bouchard,
JeanMichel Foidart,
Axelle Pintiaux
Publication year - 2008
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2008-0731
Subject(s) - endocrinology , immunostaining , stromal cell , medicine , vascular endothelial growth factor , endometrium , luteal phase , angiogenesis , von willebrand factor , progesterone receptor , in utero , immunohistochemistry , chemistry , andrology , biology , vegf receptors , estrogen receptor , platelet , pregnancy , fetus , cancer , breast cancer , hormone , genetics
VA-2914 is a selective progesterone receptor modulator with potential contraceptive activity that induces amenorrhea, whereas progestins cause endometrial spotting and bleeding. This abnormal bleeding due to progestins is a consequence of focal stromal proteolysis by an increase in naked vessel size and density.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom